196 related articles for article (PubMed ID: 11907120)
1. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.
Monneret G; Li H; Vasilescu J; Rokach J; Powell WS
J Immunol; 2002 Apr; 168(7):3563-9. PubMed ID: 11907120
[TBL] [Abstract][Full Text] [Related]
2. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
[TBL] [Abstract][Full Text] [Related]
3. A novel PGD(2) receptor expressed in eosinophils.
Powell WS
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):179-85. PubMed ID: 12895601
[TBL] [Abstract][Full Text] [Related]
4. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis.
Heinemann A; Schuligoi R; Sabroe I; Hartnell A; Peskar BA
J Immunol; 2003 May; 170(9):4752-8. PubMed ID: 12707356
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.
Ward C; Dransfield I; Murray J; Farrow SN; Haslett C; Rossi AG
J Immunol; 2002 Jun; 168(12):6232-43. PubMed ID: 12055237
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells.
Gosset P; Bureau F; Angeli V; Pichavant M; Faveeuw C; Tonnel AB; Trottein F
J Immunol; 2003 May; 170(10):4943-52. PubMed ID: 12734337
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
Monneret G; Gravel S; Diamond M; Rokach J; Powell WS
Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533
[TBL] [Abstract][Full Text] [Related]
9. 15-deoxy-Δ¹²,¹⁴-PGJ₂ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis.
Koyani CN; Windischhofer W; Rossmann C; Jin G; Kickmaier S; Heinzel FR; Groschner K; Alavian-Ghavanini A; Sattler W; Malle E
Int J Cardiol; 2014 May; 173(3):472-80. PubMed ID: 24698234
[TBL] [Abstract][Full Text] [Related]
10. The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1.
Lee JH; Woo JH; Woo SU; Kim KS; Park SM; Joe EH; Jou I
J Immunol; 2008 Dec; 181(12):8642-9. PubMed ID: 19050284
[TBL] [Abstract][Full Text] [Related]
11. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes.
Shibata T; Kondo M; Osawa T; Shibata N; Kobayashi M; Uchida K
J Biol Chem; 2002 Mar; 277(12):10459-66. PubMed ID: 11786541
[TBL] [Abstract][Full Text] [Related]
12. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
Kim HY; Kim HS
Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.
Harris SG; Phipps RP
Immunology; 2002 Jan; 105(1):23-34. PubMed ID: 11849312
[TBL] [Abstract][Full Text] [Related]
16. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
17. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
[TBL] [Abstract][Full Text] [Related]
18. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression.
Liu JD; Tsai SH; Lin SY; Ho YS; Hung LF; Pan S; Ho FM; Lin CM; Liang YC
Life Sci; 2004 Mar; 74(19):2451-63. PubMed ID: 14998722
[TBL] [Abstract][Full Text] [Related]
19. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
[TBL] [Abstract][Full Text] [Related]
20. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
